Search

everythinglearnresearchcommunity

for

Search:↓

Early onset hair loss linked to genetics and androgen levels.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Minoxidil treatment may cause hair loss.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Transplanting hair follicles into chronic ulcers helps them heal better.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A woman's chronic head pain after hair transplant surgery was cured by removing a post-traumatic neuroma.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.